Hello, Welcome to Shine Consultant !
Summit & Event Advisor & Insight Research & Analysis
Guest Information
发布时间: 2021 - 08 - 18
点击次数: 0
Positions: Partner, Litigation Department
Company: Paul Hastings
个人简介:
Phoebe Yan is a litigation partner based in our Shanghai office. Her practice focuses on life science, white-collar crime and internal investigations, government enforcement actions, and dispute resolution. Ms. Yan specializes in cross-border compliance and contentious matters. Ms. Yan is admitted to practice law in New York. She also passed the bar in China in 2013 and has a Chinese practicing license, but the license is currently not in active status due to local regulatory requirements. Before joining Paul Hastings, Ms. Yan worked at a full-service Chinese law firm and an international law firm.
发布时间: 2021 - 08 - 18
点击次数: 0
Positions: Of Counsel, Litigation Department
Company: Paul Hastings
个人简介:
Sarah Zhu is an Of counsel in the litigation department of Paul Hastings. Ms. Zhu has particular experience in dispute resolution through international arbitrations under UNCITRAL, CIETAC, SIAC, HKIAC and iCC and cross-border litigations. Ms. Zhu is also experienced in compliance matters including government and internal investigations, pre-transaction due diligence, post-transaction compliance program implementation, and risk assessment involving issues relating to corruption. fraud, and sanctions. Ms. Zhu is a Registered Foreign Lawyer (New York) in Hong Kong. She has also passed the PRC bar exam and had held a practicing license at the time when she was practicing at a top PRC law firm.
发布时间: 2021 - 08 - 18
点击次数: 0
Positions: CEO
Company: Hua Medicine (Shanghai) Ltd.
个人简介:
Dr. Li Chen, Founder, Executive Director, CEO, and CSO. Hua Medicine leverages global resources to develop GKA and completed 6 clinical studies in China and USA, in which the HMS5552, a novel GK PAM demonstrated desirable safety and efficacy profiles together with an improvement of beta cell function in Chinese T2DM patients. Hua Medicine completed successfully a POC study and initiated China NDA enabling process. Li received his PhD at Iowa State University and joined Roche R&D center in USA in 1992 and advanced his career to CSO of Roche China R&D Center. He is an inventor of 55 granted patents and an author with over 60 publications.
发布时间: 2021 - 08 - 18
点击次数: 0
Positions: Founder, Chairman
Company: I-Mab Biopharma
个人简介:
Dr. Zang founded I-Mab in 2016 and brought the Company to NASDAQ in early 2020. Under his leadership, I-Mab has evolved from an early-stage discovery company into a clinical stage company with an innovative and globally competitive pipeline in only four years. Prior to founding I-Mab, Dr. Zang held various senior executive positions in global and China pharma groups, including Senior Vice President and head of Neuroscience Therapeutic Area and head of China R&D Center with GlaxoSmithKline and Chief Scientific Officer and President with Simcere Pharmaceuticals and BioSciKin, an innovative drug development platform. Dr. Zang started his academic pursuit at Dr. L. Willems Institute in Belgium where he was head of multiple sclerosis research unit and later became Professor of Neurology and Immunology and Research Director of Multiple Sclerosis Center at Baylor College of Medicine in US. During his academic career in China, Dr. Zang founded the Institute of Health Sciences and co-founded the Institute Pasteur Shanghai with the Chinese Academy of Sciences. He also served as Dean of School of Medical Sciences at the Shanghai JiaoTong University and Director of Shanghai Institute of Immunology. Dr. Zang published more than 130 scientific articles and book chapters in prestigious journals and publications, including in Science, Nature Medicine, Nature Immunology, Immunity. Dr. Zang received his medical degree from Shanghai JiaoTong University School of Medicine, Ph.D. in Immunology from University of Brussels and completed his postdoctoral fellowship at Harvard Medical School. Dr. Zang is a licensed physician (Texas Medical Board) in US.